Arcturus Therapeutics Holdings (ARCT) Tax Provisions (2022 - 2025)
Arcturus Therapeutics Holdings (ARCT) reported Tax Provisions of -$4000.0 for Q4 2025, little changed on a YoY basis from -$4000.0 in Q4 2024, and down 200.0% quarter-over-quarter from $4000.0 in Q2 2025.
Arcturus Therapeutics Holdings (ARCT) Tax Provisions (2022 - 2025) Analysis & Trends
Arcturus Therapeutics Holdings has reported Tax Provisions for 4 years, with the latest figure at -$4000.0 in Q4 2025.
- For the quarter ending Q4 2025, Tax Provisions changed 0.0% year-over-year to -$4000.0; the trailing twelve-month figure through Jun 2025 stood at -$217000.0 (down 115.37% YoY), and the FY2024 full-year result was -$4000.0, down 100.22% from the prior year.
- Tax Provisions for Q4 2025 stood at -$4000.0, down from $4000.0 in the prior quarter.
- The five-year high for Tax Provisions was $900000.0 in Q3 2023, with the low at -$217000.0 in Q3 2024.
- Historically, Tax Provisions has averaged $178909.1 across 4 years, with a median of $100000.0 in 2022.
- The largest YoY upside for Tax Provisions was 300.0% in 2024 against a maximum downside of 126.0% in 2024.
- Arcturus Therapeutics Holdings' Tax Provisions stood at $100000.0 in 2022, then soared by 162.0% to $262000.0 in 2023, then plunged by 101.53% to -$4000.0 in 2024, then changed by 0.0% to -$4000.0 in 2025.
- The last three Tax Provisions figures came in at -$4000.0 (Q4 2025), $4000.0 (Q2 2025), and -$4000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arcturus Therapeutics Holdings | 217.14 Mn | 5.76 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Dec 31, 2024 | -4,000.00 |
| Sep 30, 2024 | -217,000.00 |
| Jun 30, 2024 | -150,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | 262,000.00 |
| Sep 30, 2023 | 900,000.00 |
| Jun 30, 2023 | 577,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Mar 31, 2022 | 100,000.00 |